✦ LIBER ✦

Efficacy and Safety of Once-Daily Linaclotide Administered Orally for 26 Weeks in Patients With IBS-C: Results From a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

✍ Scribed by William D. Chey; Anthony Lembo; James E. MacDougall; Bernard J. Lavins; Harvey Schneier; Jeffrey M. Johnston

Book ID: 119432397
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 468 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(11)60550-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

286 Efficacy and Safety of Once Daily Li

286 Efficacy and Safety of Once Daily Linaclotide Administered Orally for 12-Weeks in Patients With Chronic Constipation: Results From 2 Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials

✍ Anthony Lembo; Harvey Schneier; Bernard J. Lavins; Steven J. Shiff; James E. Mac 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Efficacy and Safety of Once Daily Linacl

Efficacy and Safety of Once Daily Linaclotide in Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial Followed by a 4-Week Randomized Withdrawal Period

✍ Satish Rao; Anthony Lembo; Steven J. Shiff; Kelvin Shi; Jeffrey M. Johnston; Har 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 504 KB

Efficacy and Safety of Acotiamide (Z-338

Efficacy and Safety of Acotiamide (Z-338) Administered Orally for 4-Weeks in Patients With Functional Dyspepsia: Results From a Randomized, Double-Blind, Placebo-Controlled Phase III Trial in Japan

✍ Kei Matsueda; Michio Hongo; Jan F. Tack; Youichi Saito; Hiroki Kato 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Efficacy and safety of golimumab in pati

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial

✍ Robert D. Inman; John C. Davis Jr.; Désirée Van Der Heijde; Laura Diekman; Joach 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

## Abstract ## Objective To evaluate the efficacy and safety of golimumab in patients with ankylosing spondylitis (AS) in the GO‐RAISE study. ## Methods Patients with active AS, a Bath AS Disease Activity Index (BASDAI) score ≥4, and a back pain score of ≥4 were randomly assigned in a 1.8:1.8:1

Efficacy and safety of solifenacin succi

Efficacy and safety of solifenacin succinate 10 mg once Daily: A multicenter, phase III, randomized, double-blind, placebo-controlled, parallel-group trial in patients with overactive bladder

✍ Franklin Chu; Neila Smith; Takeshi Uchida 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Efficacy and safety of adalimumab in pat

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial

✍ Désirée van der Heijde; Alan Kivitz; Michael H. Schiff; Joachim Sieper; Ben A. C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views